Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 3
1991 1
1992 1
1994 1
1997 1
2000 3
2001 1
2002 4
2004 3
2005 4
2006 8
2007 7
2008 4
2009 6
2010 8
2011 7
2012 7
2013 8
2014 6
2015 10
2016 5
2017 5
2018 7
2019 10
2020 6
2021 7
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Results by year
Filters applied: . Clear all
Page 1
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
Nelde A, Bilich T, Heitmann JS, Maringer Y, Salih HR, Roerden M, Lübke M, Bauer J, Rieth J, Wacker M, Peter A, Hörber S, Traenkle B, Kaiser PD, Rothbauer U, Becker M, Junker D, Krause G, Strengert M, Schneiderhan-Marra N, Templin MF, Joos TO, Kowalewski DJ, Stos-Zweifel V, Fehr M, Rabsteyn A, Mirakaj V, Karbach J, Jäger E, Graf M, Gruber LC, Rachfalski D, Preuß B, Hagelstein I, Märklin M, Bakchoul T, Gouttefangeas C, Kohlbacher O, Klein R, Stevanović S, Rammensee HG, Walz JS. Nelde A, et al. Among authors: gouttefangeas c. Nat Immunol. 2021 Jan;22(1):74-85. doi: 10.1038/s41590-020-00808-x. Epub 2020 Sep 30. Nat Immunol. 2021. PMID: 32999467
Actively personalized vaccination trial for newly diagnosed glioblastoma.
Hilf N, Kuttruff-Coqui S, Frenzel K, Bukur V, Stevanović S, Gouttefangeas C, Platten M, Tabatabai G, Dutoit V, van der Burg SH, Thor Straten P, Martínez-Ricarte F, Ponsati B, Okada H, Lassen U, Admon A, Ottensmeier CH, Ulges A, Kreiter S, von Deimling A, Skardelly M, Migliorini D, Kroep JR, Idorn M, Rodon J, Piró J, Poulsen HS, Shraibman B, McCann K, Mendrzyk R, Löwer M, Stieglbauer M, Britten CM, Capper D, Welters MJP, Sahuquillo J, Kiesel K, Derhovanessian E, Rusch E, Bunse L, Song C, Heesch S, Wagner C, Kemmer-Brück A, Ludwig J, Castle JC, Schoor O, Tadmor AD, Green E, Fritsche J, Meyer M, Pawlowski N, Dorner S, Hoffgaard F, Rössler B, Maurer D, Weinschenk T, Reinhardt C, Huber C, Rammensee HG, Singh-Jasuja H, Sahin U, Dietrich PY, Wick W. Hilf N, et al. Among authors: gouttefangeas c. Nature. 2019 Jan;565(7738):240-245. doi: 10.1038/s41586-018-0810-y. Epub 2018 Dec 19. Nature. 2019. PMID: 30568303 Clinical Trial.
[Tumor vaccines-therapeutic vaccination against cancer].
Rammensee HG, Löffler MW, Walz JS, Bokemeyer C, Haen SP, Gouttefangeas C. Rammensee HG, et al. Among authors: gouttefangeas c. Internist (Berl). 2020 Jul;61(7):690-698. doi: 10.1007/s00108-020-00814-z. Internist (Berl). 2020. PMID: 32462251 Review. German.
Personalized cancer vaccines: adjuvants are important, too.
Gouttefangeas C, Rammensee HG. Gouttefangeas C, et al. Cancer Immunol Immunother. 2018 Dec;67(12):1911-1918. doi: 10.1007/s00262-018-2158-4. Epub 2018 Apr 11. Cancer Immunol Immunother. 2018. PMID: 29644387 Review.
Immunorejuvenation in the elderly.
Pawelec G, Koch S, Gouttefangeas C, Wikby A. Pawelec G, et al. Among authors: gouttefangeas c. Rejuvenation Res. 2006 Spring;9(1):111-6. doi: 10.1089/rej.2006.9.111. Rejuvenation Res. 2006. PMID: 16608407 Review.
Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.
Rammensee HG, Gouttefangeas C, Heidu S, Klein R, Preuß B, Walz JS, Nelde A, Haen SP, Reth M, Yang J, Tabatabai G, Bösmüller H, Hoffmann H, Schindler M, Planz O, Wiesmüller KH, Löffler MW. Rammensee HG, et al. Among authors: gouttefangeas c. Vaccines (Basel). 2021 Apr 24;9(5):428. doi: 10.3390/vaccines9050428. Vaccines (Basel). 2021. PMID: 33923363 Free PMC article.
CD4+ T Cells: Multitasking Cells in the Duty of Cancer Immunotherapy.
Richardson JR, Schöllhorn A, Gouttefangeas C, Schuhmacher J. Richardson JR, et al. Among authors: gouttefangeas c. Cancers (Basel). 2021 Feb 3;13(4):596. doi: 10.3390/cancers13040596. Cancers (Basel). 2021. PMID: 33546283 Free PMC article. Review.
Immunotherapy of renal cell carcinoma.
Gouttefangeas C, Stenzl A, Stevanović S, Rammensee HG. Gouttefangeas C, et al. Cancer Immunol Immunother. 2007 Jan;56(1):117-28. doi: 10.1007/s00262-006-0172-4. Epub 2006 May 5. Cancer Immunol Immunother. 2007. PMID: 16676181 Review.
106 results